p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells
- PMID: 10559918
- DOI: 10.1038/12027
p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells
Abstract
The F-box protein p45SKP2 is the substrate-targeting subunit of the ubiquitin-protein ligase SCFSKP2 and is frequently overexpressed in transformed cells. Here we report that expression of p45SKP2 in untransformed fibroblasts activates DNA synthesis in cells that would otherwise growth-arrest. Expression of p45SKP2 in quiescent fibroblasts promotes p27Kip1 degradation, allows the generation of cyclin-A-dependent kinase activity and induces S phase. Coexpression of a degradation-resistant p27Kip1 mutant suppresses p45SKP2-induced cyclin-A-kinase activation and S-phase entry. We propose that p45SKP2 is important in the progression from quiescence to S phase and that the ability of p45SKP2 to promote p27Kip1 degradation is a key aspect of its S-phase-inducing function. In transformed cells, p45SKP2 may contribute to deregulated initiation of DNA replication by interfering with p27Kip1 function.
Similar articles
-
Retinoic acid stabilizes p27Kip1 in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45Skp2 and Cks1 proteins.Oncogene. 2005 Apr 7;24(15):2483-94. doi: 10.1038/sj.onc.1208458. Oncogene. 2005. PMID: 15735731
-
The F-box protein SKP2 binds to the phosphorylated threonine 380 in cyclin E and regulates ubiquitin-dependent degradation of cyclin E.Biochem Biophys Res Commun. 2001 Mar 9;281(4):884-90. doi: 10.1006/bbrc.2001.4442. Biochem Biophys Res Commun. 2001. PMID: 11237742
-
Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.Virology. 2000 Feb 15;267(2):335-49. doi: 10.1006/viro.1999.0147. Virology. 2000. PMID: 10662629
-
p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation.Oncogene. 2000 Jan 6;19(1):51-60. doi: 10.1038/sj.onc.1203231. Oncogene. 2000. PMID: 10644979
-
Regulating S phase: CDKs, licensing and proteolysis.Cell. 1996 Jun 14;85(6):785-7. doi: 10.1016/s0092-8674(00)81261-1. Cell. 1996. PMID: 8681373 Review. No abstract available.
Cited by
-
Clinical significance of overexpressed cyclin-dependent kinase subunits 1 and 2 in esophageal carcinoma.Dis Esophagus. 2013 Sep-Oct;26(7):729-36. doi: 10.1111/dote.12013. Epub 2013 Jan 10. Dis Esophagus. 2013. PMID: 23301842 Free PMC article.
-
Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase.Protein Cell. 2013 Feb;4(2):103-16. doi: 10.1007/s13238-012-2105-7. Epub 2012 Nov 8. Protein Cell. 2013. PMID: 23136067 Free PMC article. Review.
-
PTEN loss promotes Warburg effect and prostate cancer cell growth by inducing FBP1 degradation.Front Oncol. 2022 Sep 27;12:911466. doi: 10.3389/fonc.2022.911466. eCollection 2022. Front Oncol. 2022. PMID: 36237339 Free PMC article.
-
Transferable domain in the G(1) cyclin Cln2 sufficient to switch degradation of Sic1 from the E3 ubiquitin ligase SCF(Cdc4) to SCF(Grr1).Mol Cell Biol. 2002 Jul;22(13):4463-76. doi: 10.1128/MCB.22.13.4463-4476.2002. Mol Cell Biol. 2002. PMID: 12052857 Free PMC article.
-
Elevating the level of Cdc34/Ubc3 ubiquitin-conjugating enzyme in mitosis inhibits association of CENP-E with kinetochores and blocks the metaphase alignment of chromosomes.J Cell Biol. 2001 Aug 20;154(4):707-17. doi: 10.1083/jcb.200104130. J Cell Biol. 2001. PMID: 11514588 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources